NSTEMI

(redirected from Non-ST-Elevation Myocardial Infarction)
AcronymDefinition
NSTEMINon-ST-Segment Elevation Myocardial Infarction
NSTEMINon-ST-Elevation Myocardial Infarction
References in periodicals archive ?
McGinn, "Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction," Journal of Thrombosis and Thrombolysis, vol.
Abbreviations ACS: Acute coronary syndrome BMS: Bare metal stents CABG: Coronary artery bypass grafting CAD: Coronary artery disease CHD: Coronary heart disease DES: Drug-eluting stents EF: Ejection fraction ITT: Intention-to-treat MACE: Major adverse cardiovascular events NSTEMI: Non-ST-elevation myocardial infarction PCI: Percutaneous coronary intervention PES: Paclitaxel-eluting stents PP: Per-protocol REVERSAL: Reversal of atherosclerosis with aggressive lipid lowering SAQ: Seattle Angina Questionnaire SES: Sirolimus-eluting stents TCM: Traditional Chinese medicine UA: Unstable angina.
BRILINTA is indicated to reduce the rate of thrombotic CV events in patients with acute coronary syndrome (ACS: unstable angina [UA], non-ST-elevation myocardial infarction [NSTEMI], or ST-elevation myocardial infarction [STEMI]).
Under the revised guidelines, BRILIQUE is listed as an antiplatelet treatment option during myocardial revascularisation for ACS patients presenting with ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI).
Cardiac troponins play a key role in differentiating patients with non-ST-elevation myocardial infarction from the large proportion of patients with acute chest pain (36); however, multiple other biomarkers have been evaluated for their diagnostic capability (7-10).
ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction) Circulation 2006; 113: 732-61.
Patients with elevated serum levels of creatine kinase myocardial band or troponin I or troponin T, but no ST-segment elevation, are said to have non-ST-elevation myocardial infarction (NSTEMI).
In these cases, cardiac troponins play a central role because they allow distinction between non-ST-elevation myocardial infarction and unstable angina, thus providing both diagnostic and prognostic information (2, 3).
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial.
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST-elevation myocardial infarction: results from a randomized trial.
reported that when anger was the trigger the patients were more likely to present with ST-elevation myocardial infarction rather than non-ST-elevation myocardial infarction or unstable angina (3).
Full browser ?